2019-09-04reuters.com

OxyContin maker Purdue Pharma LP is preparing to seek bankruptcy protection before the end of the month if it does not reach a settlement with U.S. communities over widespread opioid litigation, three people familiar with the matter said, after some states balked at the company's $10 billion to $12 billion offer in August to end their lawsuits as part of a negotiated Chapter 11 case. 

...

Strong opposition from some attorneys general such as those in Massachusetts and New York emerged last week after confidential discussions on Purdue's settlement talks became public in media reports, with Connecticut's calling for Purdue to be "broken up and shut down," and sold in parts. Their main sticking point is how much Purdue's controlling Sackler family will pay, the people said.

Purdue faces more than 2,000 lawsuits from cities, counties and states alleging it helped fuel the U.S. opioid epidemic, and Reuters reported in March that the company and family began exploring bankruptcy options for Purdue to halt lawsuits and attempt to resolve litigation with plaintiffs rather than fight every single case.



Comments: Be the first to add a comment

add a comment | go to forum thread